Singapore markets closed

GILD Jun 2024 70.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.8700-0.0800 (-1.62%)
As of 02:46PM EDT. Market open.
Full screen
Previous close4.9500
Open4.7300
Bid4.1000
Ask4.7500
Strike70.00
Expiry date2024-06-21
Day's range4.7300 - 5.0000
Contract rangeN/A
Volume16
Open interest3.49k
  • Reuters

    US FDA mandates label updates on CAR-T cancer therapies

    The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called "boxed warning" to highlight the serious risk of T-cell blood cancer in patients who use these therapies. The health regulor has required related updates to other sections of the label such as warnings and precautions, postmarketing experience, patient counseling information and medication guide. In January, the FDA asked a host of drugmakers including Gilead Sciences, Johnson & Johnson and Novartis to add a boxed warning to their CAR-T cancer therapies, as it received reports of patients developing a type of T-cell blood cancer after being treated with them.

  • Zacks

    Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know

    Gilead Sciences (GILD) closed at $66.16 in the latest trading session, marking a -1.15% move from the prior day.

  • Zacks

    Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for

    Gilead (GILD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.